190.00
+11.28
+(6.31%)
As of 10:18:32 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 22 | 22 | 27 | 27 |
Avg. Estimate | 4.86B | 5.21B | 20.87B | 22.73B |
Low Estimate | 4.73B | 5.09B | 20.45B | 22.18B |
High Estimate | 5.15B | 5.53B | 22.25B | 24.29B |
Year Ago Sales | 4.54B | 4.79B | 19.12B | 20.87B |
Sales Growth (year/est) | 6.94% | 8.67% | 9.15% | 8.88% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
FIV.F | -- | -- | -- | -- |
S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
Upgrade | Goldman Sachs: Neutral to Buy | 4/2/2025 |
Maintains | Susquehanna: Positive to Positive | 2/10/2025 |
Maintains | Barclays: Overweight to Overweight | 2/10/2025 |
Maintains | RBC Capital: Outperform to Outperform | 2/6/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 2/6/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 2/6/2025 |